Corbus Pharmaceuticals Holdings (CRBP) SG&A Expense (TTM): 16.62M | YCharts

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

2.86 -0.71 (-19.89%) USD | NASDAQ | Nov 05, 16:00

2.90 +0.04 (+1.40%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Start Trial.

Date	Value
June 30, 2026	16.62M
March 31, 2026	15.57M
December 31, 2025	15.22M
September 30, 2025	15.47M
June 30, 2025	16.61M
March 31, 2025	16.77M
December 31, 2024	16.50M
September 30, 2024	15.80M
June 30, 2024	14.04M
March 31, 2024	13.86M
December 31, 2023	13.91M
September 30, 2023	15.34M
June 30, 2023	16.48M
March 31, 2023	17.38M
December 31, 2022	18.70M
September 30, 2022	18.38M
June 30, 2022	19.58M
March 31, 2022	20.32M
December 31, 2021	20.43M
September 30, 2021	21.55M
June 30, 2021	23.96M
March 31, 2021	26.12M
December 31, 2020	28.48M
September 30, 2020	29.40M
June 30, 2020	27.25M

Date	Value
March 31, 2020	24.72M
December 31, 2019	23.64M
September 30, 2019	21.10M
June 30, 2019	18.75M
March 31, 2019	16.53M
December 31, 2018	12.96M
September 30, 2018	11.79M
June 30, 2018	10.74M
March 31, 2018	9.634M
December 31, 2017	8.964M
September 30, 2017	8.957M
June 30, 2017	8.587M
March 31, 2017	7.73M
December 31, 2016	6.460M
September 30, 2016	4.934M
June 30, 2016	3.964M
March 31, 2016	3.911M
December 31, 2015	4.193M
September 30, 2015	3.839M
June 30, 2015	3.414M
March 31, 2015	2.740M
December 31, 2014	1.392M
September 30, 2014	0.7042M
June 30, 2014	0.355M
March 31, 2014	0.0778M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Heron Therapeutics, Inc.	104.50M
Tonix Pharmaceuticals Holding Corp.	125.96M
Karyopharm Therapeutics, Inc.	101.98M
Minerva Neurosciences, Inc.	19.60M
Ocugen, Inc.	21.49M